KROS |
Keros Therapeutics, Inc. |
Aug 13, 2024 |
2 |
-$11M |
4 |
Aug 15, 2024 |
Director |
TERN |
Terns Pharmaceuticals, Inc. |
Jul 15, 2024 |
6 |
-$562K |
4 |
Jul 17, 2024 |
Director, 10%+ Owner |
TERN |
Terns Pharmaceuticals, Inc. |
Jul 1, 2024 |
1 |
$0 |
4 |
Jul 2, 2024 |
Director, 10%+ Owner |
TERN |
Terns Pharmaceuticals, Inc. |
Jun 10, 2024 |
1 |
$0 |
4 |
Jun 14, 2024 |
Director, 10%+ Owner |
ACET |
Adicet Bio, Inc. |
Jun 5, 2024 |
2 |
$0 |
4 |
Jun 7, 2024 |
Director, 10%+ Owner |
KROS |
Keros Therapeutics, Inc. |
May 30, 2024 |
1 |
$0 |
4 |
Jun 3, 2024 |
Director |
KNTE |
Kinnate Biopharma Inc. |
Apr 3, 2024 |
8 |
$0 |
4 |
Apr 5, 2024 |
Director, 10%+ Owner |
THRX |
Theseus Pharmaceuticals, Inc. |
Feb 14, 2024 |
3 |
$0 |
4 |
Feb 14, 2024 |
Director, 10%+ Owner |
CMPX |
Compass Therapeutics, Inc. |
Feb 9, 2024 |
1 |
$0 |
4 |
Feb 14, 2024 |
Director, 10%+ Owner |
AVBP |
ArriVent Biopharma, Inc. |
Jan 30, 2024 |
10 |
$8M |
4 |
Jan 31, 2024 |
Director, 10%+ Owner |
ACET |
Adicet Bio, Inc. |
Jan 25, 2024 |
3 |
$7.5M |
4 |
Jan 26, 2024 |
Director, 10%+ Owner |
AVBP |
ArriVent Biopharma, Inc. |
Jan 25, 2024 |
0 |
$0 |
3 |
Jan 25, 2024 |
Director, 10%+ Owner |
ACET |
Adicet Bio, Inc. |
Aug 14, 2023 |
8 |
$0 |
4 |
Aug 16, 2023 |
Director, 10%+ Owner |
THRX |
Theseus Pharmaceuticals, Inc. |
Jul 17, 2023 |
2 |
$1.46M |
4 |
Jul 19, 2023 |
Director, 10%+ Owner |
ACET |
Adicet Bio, Inc. |
Jun 27, 2023 |
4 |
$1.83M |
4 |
Jun 29, 2023 |
Director, 10%+ Owner |
THRX |
Theseus Pharmaceuticals, Inc. |
Jun 13, 2023 |
2 |
$0 |
4 |
Jun 13, 2023 |
Director, 10%+ Owner |
TERN |
Terns Pharmaceuticals, Inc. |
Jun 12, 2023 |
1 |
$0 |
4 |
Jun 14, 2023 |
Director, 10%+ Owner |
KNTE |
Kinnate Biopharma Inc. |
Jun 12, 2023 |
1 |
$0 |
4 |
Jun 13, 2023 |
Director, 10%+ Owner |
KROS |
Keros Therapeutics, Inc. |
Jun 6, 2023 |
1 |
$0 |
4 |
Jun 8, 2023 |
Director |
ACET |
Adicet Bio, Inc. |
Jun 1, 2023 |
2 |
$0 |
4 |
Jun 2, 2023 |
Director |
KNTE |
Kinnate Biopharma Inc. |
May 4, 2023 |
5 |
$4.09M |
4 |
May 8, 2023 |
Director, 10%+ Owner |
KNTE |
Kinnate Biopharma Inc. |
Apr 28, 2023 |
9 |
$3.67M |
4 |
May 2, 2023 |
Director, 10%+ Owner |
KNTE |
Kinnate Biopharma Inc. |
Feb 17, 2023 |
2 |
$0 |
4 |
Feb 22, 2023 |
Director, 10%+ Owner |
CMPX |
Compass Therapeutics, Inc. |
Feb 8, 2023 |
1 |
$0 |
4 |
Feb 9, 2023 |
Director, 10%+ Owner |
TERN |
Terns Pharmaceuticals, Inc. |
Dec 23, 2022 |
1 |
$1M |
4 |
Dec 28, 2022 |
Director, 10%+ Owner |
CMPX |
Compass Therapeutics, Inc. |
Nov 8, 2022 |
1 |
$1.29M |
4 |
Nov 10, 2022 |
Director, 10%+ Owner |
THRX |
Theseus Pharmaceuticals, Inc. |
Nov 7, 2022 |
1 |
$1M |
4 |
Nov 9, 2022 |
Director, 10%+ Owner |
TERN |
Terns Pharmaceuticals, Inc. |
Aug 16, 2022 |
6 |
$8.93M |
4 |
Aug 18, 2022 |
Director, 10%+ Owner |
TERN |
Terns Pharmaceuticals, Inc. |
Jun 16, 2022 |
1 |
$0 |
4 |
Jun 21, 2022 |
Director, 10%+ Owner |
KNTE |
Kinnate Biopharma Inc. |
Jun 13, 2022 |
1 |
$0 |
4 |
Jun 15, 2022 |
Director |
THRX |
Theseus Pharmaceuticals, Inc. |
Jun 10, 2022 |
1 |
$0 |
4 |
Jun 13, 2022 |
Director, 10%+ Owner |
ACET |
Adicet Bio, Inc. |
Jun 2, 2022 |
1 |
$0 |
4 |
Jun 3, 2022 |
Director |
KROS |
Keros Therapeutics, Inc. |
Jun 1, 2022 |
1 |
$0 |
4 |
Jun 3, 2022 |
Director |
CMPX |
Compass Therapeutics, Inc. |
May 11, 2022 |
3 |
$420K |
4 |
May 13, 2022 |
Director, 10%+ Owner |
CMPX |
Compass Therapeutics, Inc. |
May 6, 2022 |
3 |
$197K |
4 |
May 10, 2022 |
Director, 10%+ Owner |
CMPX |
Compass Therapeutics, Inc. |
Feb 18, 2022 |
1 |
$0 |
4 |
Feb 23, 2022 |
Director, 10%+ Owner |
KNTE |
Kinnate Biopharma Inc. |
Feb 11, 2022 |
4 |
$1.99M |
4 |
Feb 15, 2022 |
Director |
THRX |
Theseus Pharmaceuticals, Inc. |
Jan 19, 2022 |
3 |
$1.58M |
4 |
Jan 21, 2022 |
Director, 10%+ Owner |
THRX |
Theseus Pharmaceuticals, Inc. |
Jan 11, 2022 |
4 |
$443K |
4 |
Jan 13, 2022 |
Director, 10%+ Owner |
ACET |
Adicet Bio, Inc. |
Dec 10, 2021 |
1 |
$3M |
4 |
Dec 14, 2021 |
Director, 10%+ Owner |
CMPX |
Compass Therapeutics, Inc. |
Nov 4, 2021 |
2 |
$18.8M |
4 |
Nov 8, 2021 |
Director, 10%+ Owner |
THRX |
Theseus Pharmaceuticals, Inc. |
Oct 12, 2021 |
7 |
$10M |
4 |
Oct 14, 2021 |
Director, 10%+ Owner |
THRX |
Theseus Pharmaceuticals, Inc. |
Oct 6, 2021 |
1 |
$0 |
4 |
Oct 8, 2021 |
Director, 10%+ Owner |
THRX |
Theseus Pharmaceuticals, Inc. |
Oct 6, 2021 |
0 |
$0 |
3 |
Oct 6, 2021 |
Director, 10%+ Owner |
IRON |
Gemini Therapeutics, Inc. /DE |
Oct 4, 2021 |
1 |
$0 |
4 |
Oct 6, 2021 |
Director, 10%+ Owner |
ORIC |
Oric Pharmaceuticals, Inc. |
Jun 16, 2021 |
1 |
$0 |
4 |
Jun 17, 2021 |
Director, 10%+ Owner |
KROS |
Keros Therapeutics, Inc. |
Jun 1, 2021 |
1 |
$0 |
4 |
Jun 3, 2021 |
Director |